查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363322

感染疾病治疗市场规模、份额和趋势分析：按疾病类型、最终用途、地区和细分趋势，2023-2030

Infectious Disease Therapeutics Market Size, Share & Trends Analysis By Disease Type (HIV, Hepatitis, Influenza, TB, Malaria, HPV), By End-use (Hospital, Clinics), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 81 Pages | 商品交期: 2-10个工作天内

价格

感染疾病治疗市场的成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球感染疾病治疗市场规模预计将达到1,152亿美元，2023年至2030年年复合成长率为7.1%。

该市场要素受到全球人类免疫力缺乏病毒（HIV）、人类乳突病毒（HPV）、结核病和肝炎病例数量不断增加的推动。

政府感染疾病和私人公司正在开拓领域进行大量投资，以预防、诊断和治疗感染疾病。提高意识提升措施预计将在预测期内提振市场。此外，由于价格下降，专利到期的增加和仿製药进入市场预计将增加对感染疾病治疗的需求。

此外，对这些感染疾病的诊断和治疗的报销以及製造商在这些疾病高发地区免费分发药品也是进一步推动市场成长的要素，值得期待。然而，感染疾病物的低普及和假药的高流行预计将成为预测期内成长抑制因素。

2016年北美市场占最大份额。大量製造商的存在、有利的报销方案以及不断上涨的医疗费用是该地区占据最大市场份额的主要要素。然而，2017 年至 2025 年，亚太地区可能会呈现最高成长率。感染疾病的高患病、亚洲国家经济状况的改善、政府采取更多倡议以增加感染疾病治疗的采用以及资金筹措活动的增加将活性化预测期内该地区的增长。这是导致最高比率的要素。

感染疾病治疗市场报告亮点

  • 2022 年，爱滋病毒领域的收益占有率最大，为 31.6%。此细分市场的推动因素包括爱滋病毒患病的活性化、对爱滋病毒感染者的资助力度不断加大、非洲国家免费爱滋病毒自我检测套组的供应量不断增加以及世界各地的宣传活动。这是造成该细分市场成长的主要要素。最大份额。
  • 预计 HPV领域在预测期内将以 8.1% 的年复合成长率成长最快。其成长的关键要素包括 HPV患病的增加以及用于治疗这种感染疾病的药物成本的下降。
  • 2022年，医院业务收入占比最大，为54.5%。报告感染疾病的紧急医院就诊次数的增加是市场的关键成长要素。
  • 2022 年，北美地区的收益占有率最大，达 39.9%。此类疾病的日益患病和有利的报销方案是推动该地区感染疾病治疗需求的主要要素。

目录

第1章调查方法和范围

第2章执行摘要

第3章感染疾病治疗市场变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 感染疾病治疗市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章感染疾病治疗：依疾病类型估计及趋势分析

  • 感染疾病治疗市场：重点
  • 感染疾病治疗市场：2022 年和 2030 年趋势和市场占有率分析
  • HIV
  • 肝炎
  • 流感
  • 结核
  • 疟疾
  • HPV

第5章感染疾病治疗：依最终用途分类的估计与趋势分析

  • 感染疾病治疗市场：重点
  • 感染疾病治疗市场：2022 年和 2030 年趋势和市场占有率分析
  • 医院
  • 诊所
  • 其他的

第6章感染疾病治疗市场：区域估计与趋势分析

  • 区域展望
  • 按地区分類的感染疾病治疗市场：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
    • Novartis AG
    • Gilead
    • GlaxoSmithKline plc
    • Janssen Pharmaceutical, Inc.
    • F. Hoffmann-La Roche Ltd.
    • BioCryst Pharmaceuticals, Inc.
    • Merck & Co., Inc.
    • Boehringer Ingelheim GmbH
Product Code: GVR-1-68038-580-9

Infectious Disease Therapeutics Market Growth & Trends:

The global infectious disease therapeutics market size is expected to reach USD 115.2 billion by 2030, registering a CAGR of 7.1% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The market is primarily driven by increasing number of Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), TB, and hepatitis cases globally.

Government and private organizations are investing heavily in the healthcare sector to prevent, diagnose, and treat infectious diseases; rising investments for development of new drugs to treat infectious diseases, and increasing number of initiatives for creating awareness about these conditions are expected to boost the market during the forecast period. Furthermore, increasing number of patent expirations and entry of generic drugs in the market are expected to increase the demand for infectious disease therapeutics due to their low prices.

In addition, availability of reimbursement for diagnosis & treatment of these infections and free distribution of drugs by manufacturers in regions with high incidence of these diseases are factors further expected to propel the market growth. However, low penetration rate of anti-infective and availability of large number of counterfeit drugs are expected to restraint the market growth during the forecast period.

North American market held the largest share in 2016. Presence of large number of manufacturers, favorable reimbursement scenario, and increasing healthcare expenditure are major factors responsible for the largest share held by this region. However, Asia Pacific is likely to grow at the highest rate between 2017 and 2025. High prevalence of infectious diseases; improving economic conditions in Asian countries, rising government initiatives to increase the adoption of treatments for infectious diseases, and rising funding activities are factors that can be attributed for the highest growth rate of this region during the forecast period.

Infectious Disease Therapeutics Market Report Highlights:

  • The HIV segment held the largest revenue share of 31.6% in 2022. The increasing prevalence of HIV, rising funding activities for patients who have HIV, increasing supply of free HIV self-test kits in African countries, and raising awareness campaigns around the globe are the key factors responsible for the largest share held by this segment.
  • The HPV segment is expected to grow at the fastest CAGR of 8.1% during the forecast period. Major factors that are responsible for its growth include the increasing prevalence of HPV and the low cost of drugs that are used in the treatment of this infection.
  • The hospital's segment held the largest revenue share of 54.5% in 2022. The increasing number of emergency hospital visits reporting infectious diseases is a significant growth factor for the market.
  • North America dominated the market with the largest revenue share of 39.9% in 2022. The increasing prevalence of such disorders and favorable reimbursement scenarios are key factors likely to propel the region's demand for infectious disease therapeutics.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Disease Type
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Disease Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Infectious Disease Therapeutics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Infectious Disease Therapeutics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Infectious Disease Therapeutics: Disease Type Estimates & Trend Analysis

  • 4.1. Infectious Disease Therapeutics Market: Key Takeaways
  • 4.2. Infectious Disease Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. HIV
    • 4.3.1. HIV market estimates and forecasts, 2018 to 2030, (USD Billion)
  • 4.4. Hepatitis
    • 4.4.1. Hepatitis market estimates and forecasts, 2018 to 2030, (USD Billion)
  • 4.5. Influenza
    • 4.5.1. Influenza market estimates and forecasts, 2018 to 2030, (USD Billion)
  • 4.6. TB
    • 4.6.1. TB market estimates and forecasts, 2018 to 2030, (USD Billion)
  • 4.7. Malaria
    • 4.7.1. Malaria market estimates and forecasts, 2018 to 2030, (USD Billion)
  • 4.8. HPV
    • 4.8.1. HPV market estimates and forecasts, 2018 to 2030, (USD Billion)

Chapter 5. Infectious Disease Therapeutics: End Use Estimates & Trend Analysis

  • 5.1. Infectious Disease Therapeutics Market: Key Takeaways
  • 5.2. Infectious Disease Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030, (USD Billion)
  • 5.4. Clinics
    • 5.4.1. Clinic market estimates and forecasts, 2018 to 2030, (USD Billion)
  • 5.5. Others
    • 5.5.1. Other market estimates and forecasts, 2018 to 2030, (USD Billion)

Chapter 6. Infectious Disease Therapeutics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Infectious Disease Therapeutics Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.6. Denmark
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.7. Sweden
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.8. Norway
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Novartis AG
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Gilead
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. GlaxoSmithKline plc
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Janssen Pharmaceutical, Inc.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. F. Hoffmann-La Roche Ltd.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. BioCryst Pharmaceuticals, Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Merck & Co., Inc.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Boehringer Ingelheim GmbH
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 3 North America infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 4 North America infectious disease therapeutics market, by region, 2018 - 2030 (USD Billion)
  • Table 5 U.S. infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 6 U.S. infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 7 Canada infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 8 Canada infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 9 Europe infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 10 Europe infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 11 Europe infectious disease therapeutics market, by region, 2018 - 2030 (USD Billion)
  • Table 12 Germany infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 13 Germany infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 14 UK infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 15 UK infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 16 France infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 17 France infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 18 Italy infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 19 Italy infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 20 Spain infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 21 Spain infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 22 Denmark infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 23 Denmark infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 24 Sweden infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 25 Sweden infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 26 Norway infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 27 Norway infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 28 Asia Pacific infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 29 Asia Pacific infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 30 Asia Pacific infectious disease therapeutics market, by region, 2018 - 2030 (USD Billion)
  • Table 31 Japan infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 32 Japan infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 33 China infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 34 China infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 35 India infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 36 India infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 37 Australia infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 38 Australia infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 39 Thailand infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 40 Thailand infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 41 South Korea infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 42 South Korea infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 43 Latin America infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 44 Latin America infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 45 Latin America infectious disease therapeutics market, by region, 2018 - 2030 (USD Billion)
  • Table 46 Brazil infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 47 Brazil infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 48 Mexico infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 49 Mexico infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 50 Argentina infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 51 Argentina infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 52 Middle East and Africa infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 53 Middle East and Africa infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 54 Middle East and Africa infectious disease therapeutics market, by region, 2018 - 2030 (USD Billion)
  • Table 55 South Africa infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 56 South Africa infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 57 Saudi Arabia infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 58 Saudi Arabia infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 59 UAE infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 60 UAE infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 61 Kuwait infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 62 Kuwait infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Infectious disease therapeutics: Market outlook
  • Fig. 8 Infectious disease therapeutics: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Infectious disease therapeutics market driver impact
  • Fig. 14 Infectious disease therapeutics market restraint impact
  • Fig. 15 Infectious disease therapeutics market strategic initiatives analysis
  • Fig. 16 Infectious disease therapeutics market: Disease type movement analysis
  • Fig. 17 Infectious disease therapeutics market: Disease type outlook and key takeaways
  • Fig. 18 HIV market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 19 Hepatitis market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 20 Influenza market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 21 TB market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Malaria market estimates and forecasts, 2018 - 2030
  • Fig. 23 HPV market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 24 Infectious disease therapeutics market: End Use movement analysis
  • Fig. 25 Infectious disease therapeutics market: End Use outlook and key takeaways
  • Fig. 26 Hospitals market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 27 Clinics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 29 Global infectious disease therapeutics market: Regional movement analysis
  • Fig. 30 Global infectious disease therapeutics market: Regional outlook and key takeaways
  • Fig. 31 North America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 32 U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 33 Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 34 Europe market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 UK market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 France market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 45 China market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 India market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 Latin America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 53 Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 55 South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)